Table 12.
Phytochemicals | Part used | Extracts/essential oil | Analytical method | In vivo/In vitro | Pharmacological activity | Geographic area | References |
---|---|---|---|---|---|---|---|
Tomentosin | Aerial parts | -Dichloromethane extract - Ethanol extract |
LC-MS/MS, TLC | In vitro | - Antidiabetic effect by inhibition of α-amylase and α-glucosidase | Turkey | 73 |
Aerial parts | - Hexane extract - Methanolic extract |
GC/MS, 1H and 13C NMR | In vitro | - Cytotoxic effects on HeLa and SiHa cell lines in cervical cancer by induction of apoptosis through mitochondria-mediated signaling pathway | Morocco | 72 | |
Inulae flos | Ethanolic extract | HPLC, 1H and 13C NMR | In vitro | - Anti-inflammatory effects by suppressing the production of inflammatory mediators in RAW264.7 cells. | Korea | 109 | |
Flowered twigs | ND | ND | In vitro | Anti-inflammatory activity by inhibition of secretory phospholipase A2 (sPLA2) from bee venom, cyclooxygenase 1 (COX1) and leukocyte elastase. | Spain | 108 | |
Flowers | Petroleum ether | 1H 13C NMR, TLC, GC-MS | In vitro | Antifungal activity against Microsporum canis, Microsporum gypseum and Trichophyton mentagrophytes at a dose of 1 mg/mL | Italy | 107 | |
Inuviscolide | Aerial parts | Acetonic extract | TLC, 1H and 13C NMR, UV, LC | In vivo/in vivo | Anti-inflammatory effect by reduction of PLA2 induced edema in rat paws, and a reduction of Leukotriene B4 production in rat neutrophils. | Spain | 55 |
Inuviscolide + Tomentosin | Leaves | Aqueous extract | TLC, 1H and 13C NMR | In vitro | - Antitumoral effect against human Melanoma SK-28, 624 mel, and 1363 mel cell lines by inhibited the proliferation and inducing cell cycle arrest at G2/M and apoptosis | Israel | 113 |
Inuviscolide + Tomentosin | Leaves | Aqueous extract | TLC, 1H and 13C NMR | In vitro | Anti-inflammatory effect by the inhibition of the secretion of inflammatory cytokines and downregulation of NFκB and STAT1. | Israel | 112 |
Dehydrocostic acid | Flowered aerial parts | Actonic extract | ND | In vivo/in vitro | Anti-inflammatory activity evidenced by inhibition of pro-inflammatory enzymes (elastase and sPLA2) and control of leukotriene B4 release | Spain | 110 |
Ilicic Acid | Aerial parts | Acetonic extract | TLC, 1H and 13C NMR, UV, LC | In vivo/in vitro | Anti-inflammatory effect by inhibiting ear edema induced by TPA in rats | Spain | 55 |
Bornyl Acetate | Aerial parts | Essential oil | ND | In vitro | Antineoplastic activity against various cancers: Cervix (HeLa), Colon (HT29), Lung (A549), Breast (MCF7). | Turkey | 69 |
Isocostic acid | Leaves | Essential oil | LC, 1H and 13C NMR, GC-FID and GC/MS | In vitro | - Antityrosinase activity, antibacterial activity and anti-inflammatory proprieties by inhibition of 5-lipoxygenase. | Tunisia | 63 |
Nepetin, Hispidulin 3-O-methylquercetin 3,3′-di-O-methylquercetin |
Aerial parts | - Ethanol extract | Column Chromatography, TLC, 1H NMR, 13C NMR | In vitro | - Antiproliferative activity against MCF-7 cells and antimicrobial effects | Jordan | 74 |
1,3-dicaffeoylquinic acid | Leaves | Methanolic extract | HPLC, 1Hand 13C NMR | In vitro | Antioxidant activity by direct scavenging multiple types of free radicals (FeSO4, AAPH, ROS, hydroxyl and superoxide radicals) | Israel | 114 |
sakuranetin, 7-O-methylaromadendrin, and 3-acetyl-7-O- methylaromadendrin |
Flowering aerial parts | Dichloromethane extract | TLC, 1H and 13c NMR | In vivo/in vitro | - Inflammatory activity: 7-O-methylaromadendrin: Potent against PLA2-edema (ED50 = 8 mg/kg). Sakuranetin: Effective on PLA2-edema (ED50 = 18 mg/kg); TPA-edema (ED50 = 205 μg/ear); inhibits LTB4 (IC50 = 9 μM) and 5-LOX. 3-Acetyl-7-O-methylaromadendrin: Leads TPA-edema reduction (ED50 = 185 μg/ear); inhibits LTB4 (IC50 = 15 μM) without affecting 5-LOX. Elastase Release: Sakuranetin at 100 μM inhibits release, indicating 5-LOX selectivity. |
Spain | 111 |
Taxifolin, Quercetin |
Leaves | Ethanolic extract | Column chromatography, TLC, 1D & 2D NMR | In vitro | Antioxidant activity: - ABTS: * Quercetin. IC50 = 41.27 μg/mL * Taxifolin IC50 = 142.58 μg/mL - DPPH: * Quercetin. IC50 = 62.53 μg/mL * Taxifolin IC50 = 103.46 μg/mL |
Morocco | 75 |
ND: Not determined.